Body mass, cardiovascular risk and metabolic characteristics of young persons presenting for mental healthcare in Sydney, Australia

BMJ Open

Volumn 5, Issue 3, 2015, Pages

  Scott, Elizabeth M ^a   Hermens, Daniel F ^a   White, Django ^a   Naismith, Sharon L ^a   GeHue, Jeanne ^a   Whitwell, Bradley G ^a   Glozier, Nick ^a   Hickie, Ian B ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN; PSYCHOTROPIC AGENT; TRIACYLGLYCEROL; ANTIDEPRESSANT AGENT; GLUCOSE BLOOD LEVEL; NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; ANXIETY; ARTICLE; AUSTRALIA; AUSTRALIAN; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; BODY MASS; CARDIOMETABOLIC RISK; CARDIOVASCULAR RISK; CHILD; CLINICAL ASSESSMENT; CROSS-SECTIONAL STUDY; DEPRESSION; FATIGUE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MANIA; MENTAL DISEASE; MENTAL HEALTH; MENTAL HEALTH CARE; OUTCOME ASSESSMENT; PRIMARY MEDICAL CARE; PULSE RATE; RISK FACTOR; SMOKING; SOCIAL INTERACTION; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; AGE; ANALYSIS; BLOOD; BLOOD PRESSURE; BODY WEIGHT; HEART RATE; MENTAL DISORDERS; OBESITY; PATHOPHYSIOLOGY; SEX DIFFERENCE; SOCIOECONOMICS; YOUNG ADULT;

ADOLESCENT; AGE FACTORS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; AUSTRALIA; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HEART RATE; HUMANS; LIPOPROTEINS, HDL; MALE; MENTAL DISORDERS; OBESITY; RISK FACTORS; SEX FACTORS; SMOKING; SOCIOECONOMIC FACTORS; THINNESS; TRIGLYCERIDES; YOUNG ADULT;

EID: 84926675435     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-007066     Document Type: Article

References (45)

1. Lopez AD, Mathers CD, Ezzati M, et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006;367:1747-57.
2. Gustavsson A, Svensson M, Jacobi F, et al. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 2011;21:718-79.
3. Bensenor IM, Brunoni AR, Pilan LA, et al . Cardiovascular risk factors in patients with first-episode psychosis in Sao Paulo, Brazil. Gen Hosp Psychiatry 2012;34:268-75.
4. Perez-Iglesias R, Martinez-Garcia O, Pardo-Garcia G, et al. Course of weight gain and metabolic abnormalities in first treated episode of psychosis: the first year is a critical period for development of cardiovascular risk factors. Int J Neuropsychopharmacol 2014;17:41-51.
5. Insel TR. The arrival of preemptive psychiatry. Early Interv Psychiatry 2007;1:5-6.
6. Insel TR. Translating scientific opportunity into public health impact: a strategic plan for research on mental illness. Arch Gen Psychiatry 2009;66:128-33.
7. Hickie IB, Scott EM, Hermens DF, et al. Applying clinical staging to young people who present for mental health care. Early Interv Psychiatry 2013;7:31-43.
8. Scott EM, Hermens DF, Glozier N, et al. Targeted primary care-based mental health services for young Australians. Med J Aust 2012;196:136-40.
9. McGorry PD, Yung AR, Pantelis C, et al. A clinical trials agenda for testing interventions in earlier stages of psychotic disorders. Med J Aust 2009;190(4 Suppl):S33-6.
10. Scott J, Leboyer M, Hickie I, et al. Clinical staging in psychiatry: a cross-cutting model of diagnosis with heuristic and practical value. Brit J Psychiatry 2013;202:243-5.
11. McGorry PD, Hickie IB, Yung AR, et al. Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust N Z J Psychiatry 2006;40:616-22.
12. Hickie IB, Groom GL, McGorry PD, et al. Australian mental health reform: time for real outcomes. Med J Aust 2005;182:401-6.
13. Huang RC, Stanley FJ, Beilin LJ. Childhood obesity in Australia remains a widespread health concern that warrants population-wide prevention programs. Med J Aust 2009;191:45-6.
14. Parikh NI, Hwang SJ, Larson MG, et al. Parental occurrence of premature cardiovascular disease predicts increased coronary artery and abdominal aortic calcification in the Framingham Offspring and Third Generation cohorts. Circulation 2007;116:1473-81.
15. Manzanares N, Monseny R, Ortega L, et al . Unhealthy lifestyle in early psychoses: the role of life stress and the hypothalamic-pituitary-adrenal axis. Psychoneuroendocrinology 2014;39:1-10.
16. Hennekens CH, Hennekens AR, Hollar D, et al. Schizophrenia and increased risks of cardiovascular disease. Am Heart J 2005;150:1115-21.
17. Marazziti D, Rutigliano G, Baroni S, et al. Metabolic syndrome and major depression. CNS Spectr 2014;19:293-304.
18. Goldstein BI, Fagiolini A, Houck P, et al. Cardiovascular disease and Metabolic syndrome and major depression hypertension among adults with bipolar I disorder in the United States. Bipolar Disord 2009;11:657-62.
19. Nadeau KJ, Maahs DM, Daniels SR, et al. Childhood obesity and cardiovascular disease: links and prevention strategies. Nature reviews. Cardiology 2011;8:513-25.
20. Cooper J, Mancuso SG, Borland R, et al. Tobacco smoking among people living with a psychotic illness: the second Australian survey of psychosis. Aust N Z J Psychiatry 2012;46:851-63.
21. Hickie IB, Scott J, McGorry PD. Clinical staging for mental disorders: a new development in diagnostic practice in mental health. Med J Aust 2013;198:461-2.
22. Hickie IB, Scott J, Hermens DF, et al. Clinical classification in mental health at the cross-roads: which direction next? BMC Med 2013;11:125.
23. Hickie IB, Hermens DF, Naismith SL, et al. Evaluating differential developmental trajectories to adolescent-onset mood and psychotic disorders. BMC Psychiatry 2013;13:303.
24. Hamilton BA, Naismith SL, Scott EM, et al. Disability is already pronounced in young people with early stages of affective disorders: data from an early intervention service. J Affect Disord 2011;131:84-91.
25. Scott E, Naismith SL, Whitwell BG, et al. Delivering youth-specific mental health services: the advantages of a collaborative, multi-disciplinary system. Australas Psychiatry 2009;17:189-94.
26. Hermens DF, Scott EM, White D, et al. Frequent alcohol, nicotine or cannabis use is common in young persons presenting for mental healthcare: a cross-sectional study. BMJ Open 2013;3:e002229.
27. Genuth S, Alberti KG, Bennett P, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003;26:3160-7.
28. Yudkin JS, Montori VM. The epidemic of pre-diabetes: the medicine and the politics. BMJ 2014;349:g4485.
29. Bombin I, Mayoral M, Castro-Fornieles J, et al. Neuropsychological evidence for abnormal neurodevelopment associated with early-onset psychoses. Psychol Med 2013;43:757-68.
30. Keshavan MS. Development, disease and degeneration in schizophrenia: a unitary pathophysiological model. J Psychiatr Res 1999;33:513-21.
31. Peralta V, de Jalon EG, Campos MS, et al. The meaning of childhood attention-deficit hyperactivity symptoms in patients with a first-episode of schizophrenia-spectrum psychosis. Schizophr Res 2011;126:28-35.
32. Piper M, Beneyto M, Burne TH, et al. The neurodevelopmental hypothesis of schizophrenia: convergent clues from epidemiology and neuropathology. Psychiatr Clin North Am 2012;35:571-84.
33. Benazzi F. Depression with DSM-IV atypical features: a marker for bipolar II disorder. Eur Arch Psychiatry Clin Neurosci 2000;250:53-5.
34. Marchand WR, Lee JN, Johnson S, et al. Differences in functional connectivity in major depression versus bipolar II depression. J Affect Disord 2013;150:527-32.
35. Angst J, Gamma A, Benazzi F, et al. Atypical depressive syndromes in varying definitions. Eur Arch Psychiatry Clin Neurosci 2006;256:44-54.
36. Angst J, Gamma A, Bowden CL, et al. Diagnostic criteria for bipolarity based on an international sample of 5,635 patients with DSM-IV major depressive episodes. Eur Arch Psychiatry Clin Neurosci 2012;262:3-11.
37. Diler RS, Birmaher B, Axelson D, et al. Dimensional psychopathology in offspring of parents with bipolar disorder. Bipolar Disord 2011;13:670-8.
38. Australia Bureau of Statistics. National Health Survey 2007-08. Commonwealth Government, 2009.
39. Australian Institute of Health and Welfare. 2010 National Drug Strategy Household Survey report. Drug Statistics Series No. 25. Cat. no. PHE 145. Canberra, 2011.
40. Ho M, Garnett SP, Baur LA, et al. Impact of dietary and exercise interventions on weight change and metabolic outcomes in obese children and adolescents: a systematic review and meta-analysis of randomized trials. JAMA Pediatr 2013;167:759-68.
41. Curtis J, Henry C, Watkins A, et al. Metabolic abnormalities in an early psychosis service: a retrospective, naturalistic cross-sectional study. Early Interv Psychiatry 2011;5:108-14.
42. Srihari VH, Phutane VH, Ozkan B, et al. Cardiovascular mortality in schizophrenia: defining a critical period for prevention. Schizophr Res 2013;146:64-8.
43. McGorry PD, Killackey E, Yung A. Early intervention in psychosis: concepts, evidence and future directions. World Psychiatry 2008;7:148-56.
44. Birchwood M, Todd P, Jackson C. Early intervention in psychosis. The critical period hypothesis. Br J Psychiatry Suppl 1998;172:53-9.
45. McGorry PD, Goldstone SD, Parker AG, et al. Cultures for mental health care of young people: an Australian blueprint for reform. Lancet Psychiatry 2014;1:559-68.